Literature DB >> 8613832

Psychosocial functioning and quality of life in patients with primary brain tumors.

M A Weitzner1, C A Meyers, K Byrne.   

Abstract

Perceived quality of life (QOL) was evaluated in a group of 50 patients with primary brain tumors. Participants completed two QOL measures and a demographic profile. Age was found not to be an important factor in differentiating QOL in these patients. All areas of QOL were found to be affected adversely by one or more of five factors: being female, being divorced, having bilateral tumor involvement, having received chemotherapy, and having a poor performance status. Pearson product-moment correlations conducted on the subscale and total scores of the two QOL instruments revealed that the two scales measure different QOL aspects and overlap in only a few areas. This may be related to the different measurement paradigms that these two instruments represent. This study is one of the first to evaluate the multidimensional aspects of QOL in patients with primary brain tumors, an understudied group. A prospective study of QOL in this group, already underway at the authors' institution, is needed to evaluate comprehensively the effect of different treatments and interventions on the QOL functioning of primary brain tumor patients. Additionally, this study shows that the choice of QOL instruments is very important and needs to be driven by the research question.

Entities:  

Mesh:

Year:  1996        PMID: 8613832     DOI: 10.3171/jns.1996.84.1.0029

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

1.  Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

Authors:  Victor A Levin; Surasak Phuphanich; W K Alfred Yung; Peter A Forsyth; Rolando Del Maestro; James R Perry; Gregory N Fuller; Mark Baillet
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

Review 2.  Awake surgery between art and science. Part I: clinical and operative settings.

Authors:  Andrea Talacchi; Barbara Santini; Francesca Casagrande; Franco Alessandrini; Giada Zoccatelli; Giovanna M Squintani
Journal:  Funct Neurol       Date:  2013 Jul-Sep

3.  Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.

Authors:  Daniel I Jacobs; Priya Kumthekar; Becky V Stell; Sean A Grimm; Alfred W Rademaker; Laurie Rice; James P Chandler; Kenji Muro; MaryAnne Marymont; Irene B Helenowski; Lynne I Wagner; Jeffrey J Raizer
Journal:  Neurooncol Pract       Date:  2014-05-05

4.  Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced delivery.

Authors:  Jennifer A Oberg; Amie N Dave; Jeffrey N Bruce; Stephen A Sands
Journal:  Neurooncol Pract       Date:  2014-09

5.  Facets and determinants of quality of life in patients with recurrent high grade glioma.

Authors:  A R Giovagnoli; A Silvani; E Colombo; A Boiardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

6.  Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.

Authors:  Kimberly R Porter; Usha Menon; Nicholas A Vick; John L Villano; Michael L Berbaum; Faith G Davis
Journal:  Support Care Cancer       Date:  2014-01-03       Impact factor: 3.603

7.  Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.

Authors:  Ketty Mobed; Raymond Liu; Susan Stewart; Margaret Wrensch; Lucie McCoy; Terri Rice; Michael Prados; Susan Chang
Journal:  J Support Oncol       Date:  2009 Nov-Dec

8.  Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours.

Authors:  Michelangelo Bartolo; Chiara Zucchella; Andrea Pace; Gaetano Lanzetta; Carmine Vecchione; Marcello Bartolo; Giovanni Grillea; Mariano Serrao; Cristina Tassorelli; Giorgio Sandrini; Francesco Pierelli
Journal:  J Neurooncol       Date:  2011-11-29       Impact factor: 4.130

Review 9.  Health-related quality of life in patients with high-grade glioma.

Authors:  Jin-xiang Cheng; Xiang Zhang; Bo-Lin Liu
Journal:  Neuro Oncol       Date:  2008-07-15       Impact factor: 12.300

Review 10.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.